Search
Search Results
##search.searchResults.foundPlural##
-
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
1159PDF: 857HTML: 146 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
3682PDF: 971HTML: 1175Cover: 251 -
A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report
115PDF: 55Suppl. Files: 36Html: 40Html Suppl. Files: 15 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3613PDF: 2147HTML: 7599 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3133PDF: 1207HTML: 140 -
-
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4513PDF: 1639HTML: 498 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2711PDF: 907HTML: 502 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1258PDF: 809HTML: 296 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2490PDF: 1111HTML: 7733Untitled: 346Fig2: 249Fig3: 242Fig4: 273 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4772PDF: 1845HTML: 1460 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1182PDF: 452HTML: 271 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1325PDF: 976HTML: 314 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1494PDF: 832HTML: 441 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4756PDF: 1616HTML: 8572 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
4003PDF: 1753HTML: 901Figures . Eliassian: 351 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
1002PDF: 875HTML: 259 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
2008PDF: 834HTML: 605 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2399PDF: 1094HTML: 2003 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1653PDF: 1050HTML: 462 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1376PDF: 603HTML: 23270 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10866PDF: 3430HTML: 1689 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3905PDF: 2695HTML: 1733 -
-
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1655PDF: 1070HTML: 545 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1494PDF: 516HTML: 18651Figure 1: 221Figure 2: 209Figure 3: 229Figure 4: 269Figure 5: 229 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8035PDF: 2553HTML: 2185Table 1.: 300Table 2.: 326Table 3.: 280Table 4.: 288 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
1112PDF: 788HTML: 303 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1951PDF: 648HTML: 434







